KCNQ gene family members act as both tumor suppressors and oncogenes in gastrointestinal cancers
Shorthouse, D.; Rahrmann, E.; Kosmidou, C.; Greenwood, B.; Hall, M. W. J.; Devonshire, G.; Gilbertson, R.; Fitzgerald, R.; Hall, B. A.
Show abstract
Voltage sensitive potassium channels play an important role in controlling membrane potential and ionic homeostasis in the gut and have been implicated in gastrointestinal (GI) cancers. Through large scale analysis of 1594 patients with GI cancers coupled with in vitro models we find KCNQ family genes are mutated in ~30% of patients, and play therapeutically targetable roles in GI cancer growth. KCNQ1 and KCNQ3 mediate the WNT pathway and MYC to increase proliferation, and its resultant effects on cadherins junctions. This also highlights novel roles for KCNQ3 in non-excitable tissues. We additionally discover that activity of KCNQ3 sensitises cancer cells to existing potassium channel inhibitors, and that inhibition of KCNQ activity reduces proliferation of GI cancer. These findings reveal a novel and exploitable role for potassium channels in the advancement of human cancer, and highlight that supplemental treatments for GI cancers may exist through KCNQ inhibitors. SIGNIFICANCEKCNQ channels modulate the WNT pathway and MYC signalling, and drive growth of gastrointestinal cancers. Available drugs modulate these pathways and offer therapeutic potential in gastrointestinal cancer.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals 94%
- An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma 93%
- High resolution deep mutational scanning of the melanocortin-4 receptor enables target characterization for drug discovery 93%
Similar papers in this journal
- KDML: a machine-learning framework for inference of multi-scale gene functions from genetic perturbation screens 94%
- Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance 94%
- Explainable Machine Learning Identifies Dosage Compensation Factors in Aneuploid Human Cancer Cells 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.